drugset / Trial / NCT00637780
Study To Determine The Pharmacokinetics Of Sulfasalazine In Children With Juvenile Idiopathic Arthritis
NaSingle-groupOpen-labelTreatment
Summary
This study will characterize the steady state pharmacokinetics of sulfasalazine delayed release tablets in pediatric Juvenile Idiopathic Arthritis patients. Data from this study will fulfill the post approval commitment to the FDA.
Timeline
- Start
- 2010-06
- Primary completion
- 2014-01
- Completion
- 2014-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Sulfasalazine | Small molecule | 30 mg/kg | — |
| Subject | Sulfasalazine | Small molecule | 60 mg/kg | — |